Pharmacoeconomic Aspects of Treating Childhood Pneumonia - Cost of Illness Study Based on Data from Serbia

1 Goodman D, Crocker ME, Pervaiz F, McCollum ED, Steenland K, Simkovich SM, Miele CH, Hammitt LL, Herrera P, Zar HJ, Campbell H, Lanata CF, McCracken JP, Thompson LM, Rosa G, Kirby MA, Garg S, Thangavel G, Thanasekaraan V, Balakrishnan K, King C, Clasen T, Checkley W; HAPIN Investigators. Challenges in the diagnosis of paediatric pneumonia in intervention field trials: recommendations from a pneumonia field trial working group. Lancet Respir Med. 2019;7(12):1068-1083. Search in Google Scholar

2 Elemraid MA, Muller M, Spencer DA, Rushton SP, Gorton R, Thomas MF, et al. Accuracy of the interpretation of chest radiographs for the diagnosis of paediatric pneumonia. PLoS One. 2014;9(8):e106051. Search in Google Scholar

3 Sulley S, Ndanga M. Pediatric pneumonia: An analysis of cost & outcome influencers in the United States. Int J Pediatr Adolesc Med. 2019;6(3):79-86. Search in Google Scholar

4 Gereige RS, Laufer PM. Pneumonia. Pediatr Rev. 2013;34(10):438-56. Search in Google Scholar

5 Zhang S, Sammon PM, King I, Andrade AL, Toscano CM, Araujo SN, Sinha A, Madhi SA, Khandaker G, Yin JK, Booy R, Huda TM, Rahman QS, El Arifeen S, Gentile A, Giglio N, Bhuiyan MU, Sturm-Ramirez K, Gessner BD, Nadjib M, Carosone-Link PJ, Simões EA, Child JA, Ahmed I, Bhutta ZA, Soofi SB, Khan RJ, Campbell H, Nair H. Cost of management of severe pneumonia in young children: systematic analysis. J Glob Health. 2016;6(1):010408. Search in Google Scholar

6 Farha T, Thomson AH. The burden of pneumonia in children in the developed world. Paediatr Respir Rev. 2005;6(2):76-82. Search in Google Scholar

7 Saha L, Kumari S, Khosla P, Rani A, Kaur S. Pharmacoeconomic Analysis of DrugsUsed in the Treatment of Pneumonia in Paediatric Population in a Tertiary Care Hospital in India—A Cost-of-Illness Study. Medical Sciences. 2017;5(4):33. Search in Google Scholar

8 Rascati K. Essentials of pharmacoeconomics. Second edition. Lippincott Williams & Wilkins. 2013. Search in Google Scholar

9 Husereau D, Drummond M, Petrou S. ISPOR Health Economic Evaluation Publication Guidelines-CHEERS Good Reporting Practices Task Force. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value Health. 2013; 16(2): 231-50. Search in Google Scholar

10 Јанковић МС. Дизајн истраживања. Медицинско друштво за рационалну терапију Републике Србије. Крагујевац 2016. Search in Google Scholar

11 Madsen HO, Hanehøj M, Das AR, Moses PD, Rose W, Puliyel M, et al. Costing of severe pneumonia in hospitalized infants and children aged 2-36 months, at a secondary and tertiary level hospital of a not‐for‐profit organization. Tropical Medicine & International Health. 2009;14(10):1315-22. Search in Google Scholar

12 Републички фонд за здравствено осигурање. Правилник о ценамa здравствених услуга на секундарном и терцијарном нивоу здравствене заштите. Доступно на: https://www.rfzo.rs/download/pravilnici/ugovaranje/Pravilnik%20o%20cenama%20zdravstvenih%20usluga%20na%20sekundarnom%20i%20tercijarnom%20nivou%20zz-14112014.pdf. Последњи пут посећено:08.04.2019. Search in Google Scholar

13 Републички фонд за здравствено осигурање. Листа А- Лекови који се прописују и издају на обрасцу лекарског рецепта. Доступно на: http://rfzo.rs/download/pravilnici/lekovi/A%20lista%20_%20primena%20od%2018.09.2018..pdf. Последњи пут посећено: 08.04.2019. Search in Google Scholar

14 IBM Corp. Released 2012. IBM SPSS Statistics for Windows, Version 21.0. Armonk, NY: IBM Corp. Search in Google Scholar

15 Jo C. Cost-of-illness studies: concepts, scopes, and methods. Clin Mol Hepatol. 2014;20(4):327-37. Search in Google Scholar

16 Ceyhan M, Ozsurekci Y, Aykac K, Hacibedel B, Ozbilgili E. Economic burden of pneumococcal infections in children under 5 years of age. Human vaccines & immunotherapeutics. 2018;14(1):106-10. Search in Google Scholar

17 Ayieko P, Akumu AO, Griffiths UK, English M. The economic burden of inpatient paediatric care in Kenya: household and provider costs for treatment of pneumonia, malaria and meningitis. Cost Effectiveness and Resource Allocation. 2009;7(1):3. Search in Google Scholar

18 Usuf E, Mackenzie G, Sambou S, Atherly D, Suraratdecha C. The economic burden of childhood pneumococcal diseases in The Gambia. Cost Eff Resour Alloc. 2016;14:4. Search in Google Scholar

19 Bauer TT, Welte T, Ernen C, Schlosser BM, Thate- Waschke I, de Zeeuw J and Schultze-Werninghaus G. Cost Analyses of Community-Acquired Pneumonia From the Hospital Perspective. Chest. 2005; 128(4): 2238-46. Search in Google Scholar

20 Nunes SEA, Minamisava R, Vieira MADS, Itria A, Pessoa VP Junior, Andrade ALSS, Toscano CM. Hospitalization costs of severe bacterial pneumonia in children: comparative analysis considering different costing methods. Einstein (Sao Paulo). 2017;15(2):212-219. Search in Google Scholar

21 Zhang S, Sammon PM, King I, Andrade AL, Toscano CM, Araujo SN, et al.Cost of management of severe pneumonia in young children: systematic nalysis. J Glob Health. 2016;6(1):010408. Search in Google Scholar

22 World Health Organization. Pocket book of hospital care for children: guidelines for the management of common childhood illnesses. World Health Organization; 2013. Search in Google Scholar

23 Zhang S, Sammon PM, King I, et al. Cost of management of severe pneumonia in young children: systematic analysis. J Glob Health. 2016;6(1):010408. Search in Google Scholar

24 Balfour-Lynn RE, Marsh G, Gorayi D, Elahi E, La-RovereJ. Non-invasive ventilation for children withacute respiratory failure in the developing world: literature review and an implementation example. Paediatric respiratory reviews. 2014;15(2):181-7. Search in Google Scholar